Natera Oncology

Don't miss our upcoming product presentation at the 2024 Advancing Precision Medicine Oncology Conference with #Natera's Karen Lin, PharmD, MPH! 🧬🤝 November 1 at 10:35 AM | 204A

NEW Webinar: Post-ESMO review: How molecular residual disease testing is transforming cancer care and drug development 🧬 Join us for a review of the current state of the MRD field, how the Signatera assay is influencing care, and where more effective therapies are needed for high-risk populations. #ESMO #MRD #Signatera #Natera https://ow.ly/noRh50TMEjP

Up to 30% of breast cancer survivors will face a recurrence, sometimes years after treatment. The #Signatera test detects molecular residual disease (MRD)—tiny traces of cancer cells that can remain in the body after treatment and may lead to recurrence. It can detect these signs months before imaging, giving survivors and their cancer care team more time to act. Stay ahead of recurrence—learn how Signatera can support your long-term health today: https://ow.ly/k4lf50TM1GJ #BreastCancer #Natera

We were honored to be a sponsor of the 2024 Teal Run, supporting our partners at The Teal Foundation and the entire ovarian cancer community. With a large team of Naterans in teal, we raised awareness about the importance of MRD testing through Signatera’s ctDNA testing for ovarian cancer, as well as the critical role of hereditary cancer testing for those at high risk, with a familial connection, or already diagnosed with ovarian cancer to help guide important treatment decisions. It was a day filled with hope, resilience, and a shared commitment to advancing care and support for those impacted by ovarian cancer. #TealRun #OvarianCancerAwareness #ctDNA #MRDTesting #HereditaryCancerTesting #Natera The Teal Foundation

NEW Webinar: Post-ESMO review: How molecular residual disease testing is transforming cancer care and drug development 🧬 Join us for a review of the current state of the MRD field, how the Signatera assay is influencing care, and where more effective therapies are needed for high-risk populations. #ESMO #MRD #Signatera #Natera https://ow.ly/49Ky50Tw9A7

Join us for an evening of complimentary refreshments, hors d'oeuvres, and engaging conversation at our welcome reception. It’s a great opportunity to meet fellow attendees, reconnect with colleagues, and start building meaningful connections. Register now: https://okt.to/WuECeq

When Danielle’s breast cancer molecular recurrence was detected by Natera's Signatera test, she and her doctor had incentive to act quickly. “I caught it at the molecular level and was able to intervene with treatment,” Danielle shared. Now, she’s celebrating consecutive negative Signatera tests! 💕 Hear more about her journey and how Signatera testing can help breast cancer survivors monitor for recurrences: https://ow.ly/bPsJ50TBC3S #BreastCancer #Natera

We had a beautiful day supporting the Melanoma Research Foundation at the 2024 Miles for Melanoma 5K this past weekend in New York City! 🏃♀️🖤 As a 2024 Hope Sponsor, we were thrilled to join survivors, healthcare providers, and community supporters at Pier 45 in Hudson River Park to raise awareness about melanoma prevention and contribute to research that will make a lasting impact. Our team had a fantastic time meeting so many passionate individuals, and we are proud to stand with the melanoma community. Pictured: The Natera team (Kelly Mellott, Lindsey Margulies, Halie May) at our booth, sharing information about our testing services and commitment to advancing cancer care. #MilesForMelanoma #MelanomaAwareness

Don't miss our upcoming NSGC CEU webinar🧬 Genetic Counseling in Cancer Care: ctDNA for Molecular Residual Disease (MRD) Detection & New Tools for Improved Hereditary Cancer Testing Uptake Natera is dedicated to closing the hereditary cancer testing gap, ensuring genetic information is accessible to all. Natera is providing an educational grant to NSGC to support CEUs for genetic counseling in cancer care. Register today 💻 https://ow.ly/RyyG50TjhKe #Natera #MRD #HereditaryCancer #CancerCare #Oncology

Natera was honored to support our partners Colorectal Cancer Alliance and be part of the 2024 Bottom's Up Invitational, hosted by Craig Melvin and Lindsay Czarniak. This annual event helps to raise research funds and support colorectal cancer survivors across the US. Our Natera golf team might not have brought home the trophy, but we had fun out on the course – all for a good cause! #Natera Oncology Golf Team – Naterans Kelly Mellott, Dina Scaglione, Carly Bess Scalise and Autumn Dangl, NP-C, plus actress, author and golfer Stephanie Szostak. #BottomsUp #CRCAwareness #ColorectalCancerSurvivors